Advertisement
News
Advertisement

FDA approves BG Medicine heart failure test

Tue, 11/23/2010 - 9:34am
Mass High Tech: The Journal of New England Technology

BG Medicine Inc. has received approval from the U.S. Food and Drug Administration for its cardiac test, Galectin-3, which is designed to measure galectin-3 blood levels.

The Waltham-based company is aiming for commercialization of Galectin-3 within 45 days of FDA clearance and is working with LabCorp to achieve that. BG Medicine is also working with Abbott Laboratories, Alere Inc. and bioMérieux SA to make automated versions of the Galectin-3 test for platforms related to the three companies.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading